In reply

Oncologist. 2013;18(10):1148. doi: 10.1634/theoncologist.2013-0216.

Abstract

The sensitivity analyses suggested in the Letter to the Editor by de Vries et al. was performed, but no material change in relative risk for bladder cancer was found. This is not surprising given the limited contribution of the studies excluded in the sensitivity analyses.

Publication types

  • Letter
  • Comment

MeSH terms

  • Diabetes Mellitus, Type 2 / drug therapy*
  • Humans
  • Neoplasms / chemically induced*
  • Thiazolidinediones / adverse effects*

Substances

  • Thiazolidinediones